Personal Website
For most of the twentieth century, science advanced by going deeper into narrow corridors. Biologists studied cells. Computer scientists studied algorithms. Materials engineers studied matter at the atomic scale. Each discipline built its own language, its own institutions, its own definition of progress. That era is ending. We are entering a period of bio-convergence —…
Medicine has always aspired to treat the individual. Yet for most of its history, it has treated the average. A drug approved for millions is calibrated to a statistical middle ground — effective for many, suboptimal for some, harmful for a few. That era is drawing to a close. Personalized gene editing is no longer…
Introduction: The Problem and the Shift Medicine has always been reactive. We wait for disease, then treat symptoms or slow progression. But the limits of this model are clear: chronic therapies are expensive, lifelong, and rarely curative. Genetic illnesses — from sickle cell to cystic fibrosis — expose the gap between what biology could fix…
Over the last five years, we’ve entered a phase of invention that goes far beyond incremental upgrades. This new wave of innovation is foundational. Instead of giving us slightly better smartphones or faster processors, it’s redefining core capabilities across fields like medicine, energy, quantum computing, materials science, and climate tech. These are not just improvements…